Sanofi: secret story of an industrial rout

This summer, an anti-Covid vaccine will finally come out of the Marcy-l’Etoile lines. Where, in the Lyon suburbs, a student of Louis Pasteur, Marcel Mérieux, had settled over a hundred years ago to produce his serums. Where Sanofi Pasteur, a name known around the world and a subsidiary of the Sanofi pharmaceutical group, has its most important site. There where “The world leader in influenza vaccines, pediatric vaccines and injectable polio vaccines”, according to its website, produces a good portion of the doses that will protect 500 million people each year … Except that the anti-Covid serum that will be bottled at Marcy-l’Etoile has not been developed by Sanofi Pasteur, but by its American competitor Johnson & Johnson. Same thing in Frankfurt, on another site of the group, this time on behalf of Pfizer / BioNTech. Here is our French Big Pharma relegated to the rank of vulgar subcontractor for other big names in the sector. What humiliation! “Internally, everyone’s morale is high”, admits an executive of the group.

A universal race for the anti-Covid Grail

With Sanofi, pride of French capitalism, we thought we had an undisputed champion, likely to get rid of this pandemic. “But on the Covid, what are they doing? “the whole country is now wondering. This incredible scientific-industrial sprint is won by others: the world’s number one pharmacy Pfizer allied to the German start-up

To read the remaining 94%,
test the offer at 1 € without obligation.

Leave a Reply

Your email address will not be published. Required fields are marked *